Selvi Durmuş

MicroRNAs, macrocontrol: Regulation of miRNA processing

Izabella Ślęzak-Prochazka, Selvi Durmuş, Bart‐Jan Kroesen et al. · RNA · 2010 · 265 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

Oral Availability and Brain Penetration of the B-RAF ^V600E Inhibitor Vemurafenib Can Be Enhanced by the P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) Inhibitor Elacridar

Selvi Durmuş, Rolf W. Sparidans, Els Wagenaar et al. · Molecular Pharmaceutics · 2012 · 125 citations

Medicine, Oncology, Pharmacology +16

Breast Cancer Resistance Protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1) Restrict Oral Availability and Brain Accumulation of the PARP Inhibitor Rucaparib (AG-014699)

Selvi Durmuş, Rolf W. Sparidans, Anita van Esch et al. · Pharmaceutical Research · 2014 · 99 citations

Medicine, Oncology, Pharmacology +12

Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer

Özge Saatci, Simone Borgoni, Özge Akbulut et al. · Oncogene · 2018 · 81 citations · Full text

Medicine, Cell Biology, Oncology +15

Hepatocellular Shuttling and Recirculation of Sorafenib-Glucuronide Is Dependent on Abcc2, Abcc3, and Oatp1a/1b

Aksana Vasilyeva, Selvi Durmuş, Lie Li et al. · Cancer Research · 2015 · 73 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17